Advantage Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $8K | Hold |
100
| – | – | 0.01% | 679 |
|
|
2019
Q2 | $7K | Hold |
100
| – | – | 0.01% | 706 |
|
|
2019
Q1 | $9K | Hold |
100
| – | – | 0.01% | 658 |
|
|
2018
Q4 | $7K | Hold |
100
| – | – | 0.01% | 713 |
|
|
2018
Q3 | $9K | Hold |
100
| – | – | 0.01% | 725 |
|
|
2018
Q2 | $10K | Hold |
100
| – | – | 0.01% | 640 |
|
|
2018
Q1 | $12K | Hold |
100
| – | – | ﹤0.01% | 635 |
|
|
2017
Q4 | $13K | Hold |
100
| – | – | ﹤0.01% | 641 |
|
|
2017
Q3 | $12K | Hold |
100
| – | – | ﹤0.01% | 649 |
|
|
2017
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 740 |
|
|
2017
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 797 |
|
|
2016
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 765 |
|
|
2016
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 676 |
|
|
2016
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 661 |
|
|
2016
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 646 |
|
|
2015
Q4 | $9K | Buy |
+100
| New | +$9K | ﹤0.01% | 577 |
|